Status:
UNKNOWN
Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section
Lead Sponsor:
Hospital Civil de Guadalajara
Conditions:
Anesthesia
Obstetric Anesthesia Problems
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Evaluates the effect of hyperbaric subarachnoid bupivacaine at doses of 5 mg vs 10 mg on mean arterial pressure in obese pregnant patients undergoing cesarean section
Detailed Description
Patients over 18 years of age, with a pregnancy of ≥37 weeks of gestation and adequate fetal well-being, with obesity with a BMI ≥30 kg/m2 presented for cesarean surgery will be included in the study....
Eligibility Criteria
Inclusion
- Pregnancy ≥37 weeks gestation with single fetus
- Body mass index (BMI) ≥ 30 kg/m2
- Indication of termination of pregnancy via abdominal caesarean section
- Indication of subarachnoid neuraxial block under mixed technique
- Signing of consent under information
Exclusion
- Allergy to local anesthetics
- Psychiatric treatment (antidepressants, anxiolytics, antipsychotics)
- Addiction to any type of drug
- Liver, renal, pulmonary or cardiac disease
- High blood pressure
- Type I, II and gestational diabetes
- Diagnostic of non-calming fetal state
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06060015
Start Date
August 1 2023
End Date
December 31 2024
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Civil de Guadalajara
Guadalajara, Jalisco, Mexico, 44280